The successful COVID-19 vaccine rollout in Chile: Factors and challenges.
COVID-19
Chile
Implementation Science
Vaccines
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
21
06
2021
revised:
27
07
2021
accepted:
04
09
2021
entrez:
14
9
2021
pubmed:
15
9
2021
medline:
15
9
2021
Statut:
ppublish
Résumé
As the COVID-19 pandemic continues causing problems around the world, Chile is facing a new episode of increasing cases and deaths. However, at the same time, the country has succeeded in providing vaccines for an important part of its population over a short period. What are the factors behind this successful process? What are the challenges faced by the country today? This article explores potential explanations for the "Chilean paradigm", regarding the COVID-19 vaccine rollout. Borrowing from implementation science frameworks, the analysis proposed an alternative explanation-based on multiple actors, approaches, and history-as opposed to one in which the outcome is due mainly to the government's performance. The rapid and extensive coverage of vaccination can be explained by the role played by the government and the academia in securing vaccines through a pragmatic approach; the capacity built at local level, as well as the coordination between the health system and local authorities; and favorable vaccine culture, developed through the implementation of the National Immunization Program. Short and long-term elements (such as investment in infrastructure and relationships between stakeholders, and actions carried out during the pandemic), as well as contextual factors (such as the political and socioeconomic context), provide a more complex story to explain the observed outcomes. While other countries could try to follow the Chilean example, the article shows that short-term actions are necessary but might not be sufficient to achieve results. At a global level, the situation calls for rethinking how countries will face these global challenges, including issues such as international cooperation and global health governance.
Identifiants
pubmed: 34518818
doi: 10.1016/j.jvacx.2021.100114
pii: S2590-1362(21)00031-0
pmc: PMC8425670
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100114Informations de copyright
© 2021 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Glob Health Res Policy. 2019 Aug 27;4:25
pubmed: 31485483
Vaccine. 2020 Jul 22;38(34):5424-5429
pubmed: 32620375
Rev Chil Pediatr. 2020 Aug;91(4):620-622
pubmed: 33399742
Health Expect. 2021 May 11;:
pubmed: 33974721
Isr J Health Policy Res. 2021 Jan 26;10(1):6
pubmed: 33499905
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
Rev Chilena Infectol. 2007 Jun;24(3):247-50
pubmed: 17554447
BMJ. 2021 Apr 20;373:n1023
pubmed: 33879476
Rev Chilena Infectol. 2021 Apr;38(2):178-184
pubmed: 34184707
Health Syst Reform. 2020 Jan 1;6(1):e1789031
pubmed: 32706280
Health Policy. 2018 Feb;122(2):184-191
pubmed: 29169610
Travel Med Infect Dis. 2021 Jul-Aug;42:102092
pubmed: 34051353
Public Health Pract (Oxf). 2021 Nov;2:100101
pubmed: 33686381
Appl Health Econ Health Policy. 2021 Jul;19(4):623-624
pubmed: 33973149
Lancet. 2019 Nov 9;394(10210):1697-1698
pubmed: 31709990
Lancet. 2021 Jul 10;398(10295):93
pubmed: 34246349
Implement Sci. 2013 Oct 02;8:117
pubmed: 24088228
N Engl J Med. 2021 Sep 2;385(10):875-884
pubmed: 34233097
Nature. 2021 Apr;592(7856):661
pubmed: 33907330
Front Public Health. 2021 Apr 21;9:626852
pubmed: 33968880